Literature DB >> 11472101

Variation in adenovirus receptor expression and adenovirus vector-mediated transgene expression at defined stages of the cell cycle.

M A Seidman1, S M Hogan, R L Wendland, S Worgall, R G Crystal, P L Leopold.   

Abstract

Detailed investigations have addressed the infection pathway of recombinant adenovirus (Ad) gene transfer vectors, but little attention has been paid to the influence of cell physiology on the outcome of Ad infection. Based on observations that Ad infection of clonal cell populations show cell-to-cell variability in the extent of capsid binding, we hypothesized that the cell cycle may influence the outcome of Ad infection. To address this hypothesis, we evaluated Ad association with cells in both unsynchronized and pharmacologically synchronized cell populations. In unsynchronized cell populations, elevated Ad association with cells correlated with expression of cyclin B1, a marker of entry into the M phase of mitosis. The same analysis conducted on cell populations that were synchronized at M phase (using paclitaxel or nocodazole) or at S phase (using aphidicolin) confirmed that M phase cells bound three- to sixfold more capsid compared with unsynchronized cells, which are primarily in the G(1) and G(2) phases. The elevated association of vectors with cells translated into 2.5- to 4-fold greater transgene expression 24 hours after infection. Assessment of cell surface expression of Ad receptors demonstrated that both the high-affinity coxsackie-adenovirus receptor for Ad fiber protein and the low-affinity alpha(v) integrin receptor for Ad penton base protein showed increased cell surface expression at M phase (1.5-fold and 2- to 3-fold increases, respectively). These data demonstrate that Ad infection of a homogenous population of cells can vary depending on the cell cycle stage, with enhanced Ad binding and expression correlating with the enhanced expression of Ad receptors during M phase. These observations have relevance to understanding the mechanisms of gene transfer by Ad vectors and should help in the design of in vivo gene transfer strategies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11472101     DOI: 10.1006/mthe.2001.0414

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  24 in total

1.  A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector.

Authors:  Shuji Kubo; Kohnosuke Mitani
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells.

Authors:  Theresa Vincent; Ralf F Pettersson; Ronald G Crystal; Philip L Leopold
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 3.  Transductional targeting of adenovirus vectors for gene therapy.

Authors:  J N Glasgow; M Everts; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-01-27       Impact factor: 5.987

4.  Identification of HI-like loop in CELO adenovirus fiber for incorporation of receptor binding motifs.

Authors:  Denis Y Logunov; Olga V Zubkova; Anna S Karyagina-Zhulina; Eugenia A Shuvalova; Andrei P Karpov; Maxim M Shmarov; Irina L Tutykhina; Yulia S Alyapkina; Natalia M Grezina; Natalia A Zinovieva; Lev K Ernst; Alexsandr L Gintsburg; Boris S Naroditsky
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

5.  Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control.

Authors:  Carin K Ingemarsdotter; Laura A Tookman; Ashley Browne; Katrina Pirlo; Rosalind Cutts; Claude Chelela; Karisma F Khurrum; Elaine Y L Leung; Suzanne Dowson; Lee Webber; Iftekhar Khan; Darren Ennis; Nelofer Syed; Tim R Crook; James D Brenton; Michelle Lockley; Iain A McNeish
Journal:  Mol Oncol       Date:  2014-12-29       Impact factor: 6.603

6.  5-fluorouracil and hydroxyurea enhance adenovirus-mediated transgene expression in colon and hepatocellular carcinoma cells.

Authors:  Xiao W Huang; Zhao Y Tang; Theodore S Lawrence; Ming Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2004-11-09       Impact factor: 4.553

7.  Neutralized adenovirus-immune complexes can mediate effective gene transfer via an Fc receptor-dependent infection pathway.

Authors:  Philip L Leopold; Rebecca L Wendland; Theresa Vincent; Ronald G Crystal
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

8.  Tumor antigen LRRC15 impedes adenoviral infection: implications for virus-based cancer therapy.

Authors:  Jim O'Prey; Simon Wilkinson; Kevin M Ryan
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

9.  Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro.

Authors:  Li Wang; Yunxin Zhang; Jinxia Zhao; Erlong Xiao; Jianzhong Lu; Shengjun Fu; Zhiping Wang
Journal:  Tumour Biol       Date:  2014-08-02

10.  The coxsackie B virus and adenovirus receptor resides in a distinct membrane microdomain.

Authors:  Katherine J D Ashbourne Excoffon; Thomas Moninger; Joseph Zabner
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.